| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.087 | 0.6 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.083 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.09 | 0.6 |